	US 12,403,151 B2
	Compositions for use in the promotion of intestinal muscle growth and development and associated intestinal motility
Clara Lucia Garcia-Rodenas, Forel (CH); Jose Manuel Ramos Nieves, Lausanne (CH); and Myriam Sandrine Steinmann, Echallens (CH)
Assigned to Societe des Produits Nestle S.A., Vevey (CH)
Appl. No. 16/955,504
Filed by SOCIETE DES PRODUITS NESTLE S.A., Vevey (CH)
PCT Filed Dec. 20, 2018, PCT No. PCT/EP2018/086301 § 371(c)(1), (2) Date Jun. 18, 2020, PCT Pub. No. WO2019/122190, PCT Pub. Date Jun. 27, 2019.
Claims priority of application No. 17209479 (EP), filed on Dec. 21, 2017.
Prior Publication US 2021/0008086 A1, Jan. 14, 2021
Int. Cl. A61K 31/702 (2006.01); A23L 33/00 (2016.01); A23L 33/135 (2016.01)

CPC A61K 31/702 (2013.01) [A23L 33/135 (2016.08); A23L 33/40 (2016.08)]

17 Claims

1. A method of promoting intestinal motility in an infant or a young child, the method comprising administering a nutritional composition comprising an effective amount of an oligosaccharide mixture of 2′-fucosyllactose (2-FL) and lacto-N-neotetraose (LNnT), which is the only N-acetylated oligosaccharide to the infant or the young child.